We strive to use industry-standard practices to proactively monitor and maintain website security. These practices include a combination of technical, operational and managerial controls. Security mechanisms in place include, but are not limited to, firewalls, network monitoring and encryption to protect certain sensitive transmissions of information. No security system is fail-safe, and we cannot guarantee information will never be obtained by unauthorized persons.
Our servers collect data regarding each site visitor’s session. This information is collected so we can compile and analyze usage data to provide reports to The Michael J. Fox Foundation as well as further develop the site to be more useful to visitors. Site visitors are not required to submit personal information to the website(s) we host on behalf of The Michael J. Fox Foundation. However, if they decline to do so, we may not be able to provide site users with requested content or services. Any personal information that site visitors submit through the website is owned by The Michael J. Fox Foundation, and used only to provide the contracted-for services.
Please refer to our cookie policy for information about the use of cookies and other tracking technologies on this website.
Updates to this Notice
This notice may be updated from time to time. We recommend you read the notice periodically.
Last updated on October 23, 2020
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Patients first
We strive to make progress in Parkinson's disease in the following key areas by evaluating risk, opportunities and challenges through a patient-focused lens, including:
Treatments that can slow, stop or reverse disease
Better treatments for currently unaddressed or under-addressed symptoms
Treatments to address or avoid the debilitating side effects of current PD drugs
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.
Our model is different
Our Foundation is a trusted strategic leader and partner to researchers, patients, thought leaders and philanthropists. With an unbiased expert perspective and a global network of contacts, our wide-ranging view of the field lets us collaborate to solve complex problems that require different talents and target resources where they are needed most — to pay off for patients faster.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.
We’re on a mission to meet every person with Parkinson’s online or face to face. We're committed to connecting patients and families to the robust nationwide PD community. By participating in clinical trials, advocating for Parkinson's policy or engaging in our community and Team Fox events, they are helping us carry new therapies over the goal line.